Laskin D L, Robertson F M, Pilaro A M, Laskin J D
Department of Pharmacology and Toxicology, Rutgers University, Piscataway, NJ 08855-0789.
Hepatology. 1988 Sep-Oct;8(5):1051-5. doi: 10.1002/hep.1840080512.
Phenobarbital is a potent inducer of hepatic cytochrome P-450 and is a tumor promoter in the two-stage model of liver carcinogenesis. In the present studies, we show that phenobarbital also induces an accumulation of activated macrophages in the livers of treated rats. These macrophages are larger and more stellate than resident Kupffer cells and are highly vacuolated. In addition, macrophages isolated from livers of phenobarbital-treated rats display increased phagocytosis of sheep red blood cells, chemotaxis toward the complement fragment C5a and enhanced production of hydrogen peroxide. Biologically active mediators released by activated macrophages have been implicated in tumor promotion as well as in the regulation of cytochrome P-450-mediated drug biotransformation. We propose that the activated macrophages that accumulate in the liver following phenobarbital treatment may contribute, at least in part, to the biological responses to this drug.
苯巴比妥是一种强效的肝细胞色素P - 450诱导剂,在肝癌发生的两阶段模型中是一种肿瘤促进剂。在本研究中,我们发现苯巴比妥还会诱导经处理大鼠肝脏中活化巨噬细胞的积累。这些巨噬细胞比常驻的库普弗细胞更大且更呈星状,并且高度空泡化。此外,从苯巴比妥处理大鼠肝脏中分离出的巨噬细胞对绵羊红细胞的吞噬作用增强,对补体片段C5a的趋化性增强,过氧化氢的产生也增加。活化巨噬细胞释放的生物活性介质与肿瘤促进以及细胞色素P - 450介导的药物生物转化调节有关。我们认为,苯巴比妥处理后在肝脏中积累的活化巨噬细胞可能至少部分地促成了对该药物的生物学反应。